Drug Discovery Today
DECEMBER 4, 2019
Horizon’s HAP1 cell line to be integrated in the HPA Cell Atlas program. Knockout cell models from Horizon chosen based on consistency and reproducibility demonstrated in validation studies.
Drug Discovery Today
DECEMBER 4, 2019
The $4M expansion has tripled the facility’s footprint to approximately 25,000 sq. ft, significantly expanding capacity and supporting MedPharm’s continued commitment to the topical and transdermal market.
Drug Discovery Today
DECEMBER 4, 2019
SparingVision awarded First Prize in the Biotech category during the European EIT Health Summit held in Paris from 2 to 3 December
Expert insights. Personalized for you.
40 
Let's personalize your content